Literature DB >> 1593874

Mechanism of the beneficial effects of ATP-MgCl2 following trauma-hemorrhage and resuscitation: downregulation of inflammatory cytokine (TNF, IL-6) release.

P Wang1, Z F Ba, M H Morrison, A Ayala, R E Dean, I H Chaudry.   

Abstract

Although ATP-MgCl2 improves hepatocellular function in a nonheparinized model of trauma-hemorrhage and crystalloid resuscitation, it remains unknown whether the beneficial effects of this agent are due to downregulation of the release of the inflammatory cytokines, tumor necrosis factor (TNF), and interleukin-6 (IL-6) under those conditions. To study this, rats underwent a 5-cm laparotomy (i.e., trauma induced) and were bled to and maintained at a mean arterial pressure of 40 mm Hg until 40% of maximum bleedout volume was returned in the form of Ringer's lactate (RL). The animals were then resuscitated with four times the volume of shed blood with RL over 60 min. ATP-MgCl2 (50 mumoles/kg body weight each) or an equivalent volume of normal saline was infused intravenously for 95 min. This infusion was started during the last 15 min of RL resuscitation. Plasma levels of TNF and IL-6 were measured at 1.5 hr after the completion of resuscitation by cytokine-dependent cellular assays. Hepatic blood flow was determined by in vivo indocyanine green clearance (corrected by hepatic extraction ratio for indocyanine green), radioactive microspheres, and [3H]-galactose clearance techniques. The results indicate that the levels of circulating TNF and IL-6 increased significantly in the hemorrhaged-resuscitated animals. ATP-MgCl2 treatment, however, markedly decreased the synthesis and/or release of these cytokines to levels similar to the sham group. The markedly decreased hepatic blood flow (as determined by three different methods) and hepatic extraction ratio for indocyanine green were also restored by ATP-MgCl2 treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593874     DOI: 10.1016/0022-4804(92)90117-i

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  11 in total

Review 1.  Pathological roles of purinergic signaling in the liver.

Authors:  Byron P Vaughn; Simon C Robson; Geoffrey Burnstock
Journal:  J Hepatol       Date:  2012-06-16       Impact factor: 25.083

2.  Direct peritoneal resuscitation from hemorrhagic shock: effect of time delay in therapy initiation.

Authors:  El Rasheid Zakaria; R Neal Garrison; Touichi Kawabe; Patrick D Harris
Journal:  J Trauma       Date:  2005-03

3.  17Beta-estradiol downregulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma-hemorrhage.

Authors:  Ya-Ching Hsieh; Michael Frink; Bjoern M Thobe; Jun-Te Hsu; Mashkoor A Choudhry; Martin G Schwacha; Kirby I Bland; Irshad H Chaudry
Journal:  Mol Immunol       Date:  2006-12-19       Impact factor: 4.407

Review 4.  Adenosine triphosphate: established and potential clinical applications.

Authors:  H J Agteresch; P C Dagnelie; J W van den Berg; J H Wilson
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

Review 5.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

6.  "Host tissue damage" signal ATP impairs IL-12 and IFNgamma secretion in LPS stimulated whole human blood.

Authors:  Marek Nalos; Stephen Huang; Ronald Sluyter; Alamgir Khan; Brigitte Santner-Nanan; Ralph Nanan; Anthony S McLean
Journal:  Intensive Care Med       Date:  2008-06-03       Impact factor: 17.440

Review 7.  Purinergic signalling in the liver in health and disease.

Authors:  Geoffrey Burnstock; Byron Vaughn; Simon C Robson
Journal:  Purinergic Signal       Date:  2013-11-24       Impact factor: 3.765

8.  The therapeutic potential of adenosine triphosphate as an immune modulator in the treatment of HIV/AIDS: a combination approach with HAART.

Authors:  Marc C E Wagner
Journal:  Curr HIV Res       Date:  2011-06       Impact factor: 1.581

Review 9.  Ectonucleotidases in Intestinal and Hepatic Inflammation.

Authors:  Marta Vuerich; Simon C Robson; Maria Serena Longhi
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

Review 10.  Purinergic signaling in liver disease.

Authors:  Byron P Vaughn; Simon C Robson; Maria Serena Longhi
Journal:  Dig Dis       Date:  2014-07-14       Impact factor: 2.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.